Literature DB >> 18670318

Drug interaction between complementary herbal medicines and gefitinib.

Sung-Wook Hwang, Hye-Suk Han, Kun Young Lim, Ji-Youn Han.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18670318     DOI: 10.1097/JTO.0b013e3181803f1e

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  12 in total

Review 1.  Herbal therapy use by cancer patients: a literature review on case reports.

Authors:  Oluwadamilola Olaku; Jeffrey D White
Journal:  Eur J Cancer       Date:  2010-12-23       Impact factor: 9.162

Review 2.  Critical evaluation of causality assessment of herb-drug interactions in patients.

Authors:  Charles Awortwe; Memela Makiwane; Helmuth Reuter; Christo Muller; Johan Louw; Bernd Rosenkranz
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

Review 3.  Adverse events associated with complementary and alternative medicine use in ovarian cancer patients.

Authors:  Erin S Sweet; Leanna J Standish; Barbara A Goff; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2013-04-26       Impact factor: 3.279

Review 4.  Clinical pharmacokinetics of tyrosine kinase inhibitors: focus on 4-anilinoquinazolines.

Authors:  Matthias Scheffler; Paola Di Gion; Oxana Doroshyenko; Jürgen Wolf; Uwe Fuhr
Journal:  Clin Pharmacokinet       Date:  2011-06       Impact factor: 6.447

5.  Gefitinib plus Fuzheng Kang'ai Formula () in Patients with Advanced Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutation: A Randomized Controlled Trial.

Authors:  Xiao-Bing Yang; Xiao-Shu Chai; Wan-Yin Wu; Shun-Qin Long; Hong Deng; Zong-Qi Pan; Wen-Feng He; Yu-Shu Zhou; Gui-Ya Liao; Shu-Jing Xiao
Journal:  Chin J Integr Med       Date:  2017-08-09       Impact factor: 1.978

6.  Coprescription of Chinese Herbal Medicine and Western Medications among Prostate Cancer Patients: A Population-Based Study in Taiwan.

Authors:  Yi-Hsien Lin; Kuang-Kuo Chen; Jen-Hwey Chiu
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-18       Impact factor: 2.629

7.  Inhibition of Human Cytochrome P450 Enzymes by Allergen Removed Rhus verniciflua Stoke Standardized Extract and Constituents.

Authors:  Hyunsik Jung; Sanghun Lee
Journal:  Evid Based Complement Alternat Med       Date:  2014-06-30       Impact factor: 2.629

8.  Yin-Cold or Yang-Heat Syndrome Type of Traditional Chinese Medicine Was Associated with the Epidermal Growth Factor Receptor Gene Status in Non-Small Cell Lung Cancer Patients: Confirmation of a TCM Concept.

Authors:  Yan-Juan Zhu; Hai-Bo Zhang; Li-Rong Liu; Yi-Hong Liu; Fu-Li Zhang; Jian-Ping Bai; Yong Li; Yan-Chun Qu; Xin Qu; Xian Chen; Yan Li; Shu-Yi Luo; Ai-Hua Ou
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-22       Impact factor: 2.629

9.  The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways.

Authors:  Mаhmoud Youns; Wael Abdel Halim Hegazy
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

Review 10.  Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer.

Authors:  Xue-Qing Hu; Yang Sun; Eric Lau; Ming Zhao; Shi-Bing Su
Journal:  Curr Cancer Drug Targets       Date:  2016       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.